ASTROCYTOMA
June 9, 2010   Victoria Parry, Dietetic Intern
Astrocytoma


Astrocytoma
s normally
develop in
the
cerebrum
but can
originate in
other parts
of the brain
and spinal
cord.
Astrocytes
Star-shaped glial cells located in the brain and spinal cord (CNS)
Function: Regulate external chemical environment of neurons; blood flow
in brain
Stages of Astrocytoma

   Stage 1: Pilocytic Astrocytoma

   Stage 2: Diffuse Astrocytoma

   Stage 3: Anaplastic Astrocytoma

   Stage 4: Glioblastoma Multiforme (GBM)
     Gliosarcoma
     Giant Cell Glioblastoma

                                             (1)
Examples of Astrocytomas

Low-grade Astrocytoma   Giant Cell Astrocytoma




                                                 (2)
Cause of Astrocytoma
   Currently unknown
     Cell phones
     Prophylactic Radiation
      for Acute Lymphatic
      Leukemia


   Genetics
     Family history of
      astrocytoma
     Molecular Mutation

                               (3)
Prevalence

Gender                             Age

   Male predominance                 Affects all ages
                                          10% less than 20 years
       1.18:1 Low-grade
                                          60% 20-45 years
       1.87:1 Anaplastic (Grade          30% 45 years or older
        III)
Race                               Mortality and Morbidity

   Affects all races                 Grade 1:    10 years
                                      Grade 2:    More than 5
                                       years
                                      Grade 3:    2-5 years
                                      Grade 4:    Less than 1 year
                                                                    (3)
Symptoms
   Altered development or
    growth (in children)
   Double Vision
   Drowsiness
   Eyesight Problems
   Headache
   Lethargy
   Mental Status Change
   Obtuseness
   Personality Changes
   Seizures
   Vomiting
                             (1,4
Diagnosis and Treatment
Testing:                  Treatment Options:
 Neurological Exam
                             Surgery
       Vision
                               Resection   of tumor
       Hearing
       Balance            Radiation
       Coordination
                           Chemotherapy
   Computed Tomography
                               Temozolomide
    Scan (CT)
   Magnetic Resonance
    Imaging (MRI)
   Angiogram
   Biopsy                                     (1, 2, 3, 5)
Case Study Patient Information
•   Admit Diagnosis: Aspiration
    Pneumonia, Dehydration, Sepsis
•   Sex: Female
•   Age: 36 Years Old
•   Weight: 157#
•   Height: 5’0”
•   BMI: 31
•   Ideal Body Weight: 90-110#
•   Percent Ideal Body Weight: 157%
•   Adjusted Body Weight: 114#
•   Home Diet Regimen: G-Tube with Jevity Bolus 5 Cans
    Daily
Past Medical History
   Astrocytoma
       1987: Cerebral Astrocytoma
        Surgery
       1992: Repeat Brain Surgery
   Pituitary Insufficiency
       Post radiation treatment
   Seizure Disorder
       Post brain surgery
   Hypothyroidism
   Pneumonia
   Gastrostomy Tube Placement
       2006
Social History

                    Resides with mother and
                     other family

                    Bed bound last 3-4 years

                    Home Health Care Aide
                        Three times daily

                    Nonverbal
Relevant Medications
   Os-Cal: Calcium supplement. Also
    used as antacid, phosphate binder,
    antidiarrheal

   Prilosec: Proton Pump Inhibitor. Used
    to decrease gastric acid secretion and
    increase gastric pH

   Lactinex: Lactobacillus probiotic.
    Used to aid with GI regulation and
    antidiarrheal

   Zofran: Antiemetic. Used to decrease
    vomiting

   Flagyl: Antibiotic used to treat C. diff.   (6)
    Can cause nausea, diarrhea, anorexia,
Laboratory Values
  Date      Hgb       Hct      MCV         Na+         K+            Gluc.        BUN      Creat.       Ca+
           12-18     37-47     82-101    135-155     3.5-5.5        70-120        8-26     .6-1.3     8.7-10.2



4/18     16.4      49.2      81.8       141        4.4         86            12          0.9        9.1

4/19     14.2      42.1      80.7       135        3.4         97            10          0.9        8.5

4/20     12.3      35.9      80.9       140        3.8         84            5           0.6        8.2

4/21     N/A       N/A       N/A        145        2.9         73            1           0.6        8.0

4/22     11.4      33.0      79.5       N/A        N/A         N/A           N/A         N/A        N/A

4/23     N/A       N/A       N/A        145        2.9         90            2           0.6        8.0

4/24     12.6      37.0      79.8       141        3.4         102           6           0.6        7.7

4/25     12.3      37.0      81.6       143        3.4         86            8           0.5        7.9

4/26     12.6      37.9      82.3       N/A        N/A         N/A           N/A         N/A        N/A
Laboratory Values
       Date           Alb           Alk Phos        SGOT           PO4          RBC            WBC          Cl-
                    3.4-5.0          50-136          7-47         2.5-4.9      4.2-5.4         4-10.5     96-107


4/18          N/A             N/A              N/A          N/A             6.01         16.2           100


4/19          2.4             339              43           3.2             5.21         18.4           102


4/20          N/A             N/A              N/A          N/A             4.44         12.4           107


4/21          N/A             N/A              N/A          N/A             N/A          N/A            108


4/22          2.2             232              63           N/A             4.16         7.7            N/A


4/23          2.5             257              58           N/A             N/A          N/A            107


4/24          2.3             189              32           N/A             4.63         16.7           106


4/25          2.2             187              18           N/A             4.53         14.7           109


4/26          N/A             N/A              N/A          N/A             4.60         13.4           N/A
Dietary Trigger


   Dietary Consult for Tube Feeding
    Recommendation

   Moderately Depleted Albumin Level of 2.4 and
    Pre-albumin Level of 11.6
PES Statements
   (NC-1.1) Swallowing difficulty related to
    dysphagia and past medical history as
    evidenced by patient needing Gastrostomy
    Tube for main nutrition and hydration support.

   (NI-5.1) Increased protein needs related to
    increased demand for protein as evidenced by
    moderately depleted albumin level of 2.4 and
    pre-albumin level of 11.6.

                                                     (7)
Interventions

   Await restart of tube feedings

   Recommend necessary adjustments to tube
    feeding rate and fluids

   Monitor tolerance of tube feeding
Energy, Protein, and Fluid
Needs*
   Estimated Energy Needs:
     1266   (BEE) x 1.2 x 1.1= 1,671 kcals


   Estimated Protein Needs:
     1.2-1.3g/kg=   62-68g


   Estimated Fluid Needs:
     35mL/kg=   1,820mL

    *All needs based on Adjusted Body Weight of 114#
Tube Feeding
Recommendations
Initial MD Order                    RD Recommended Order*

   Jevity 1.5 at 30cc/hr              Jevity 1.5 at 50cc/hr
                                       Provides:
   Provides:                              1,800 kcals
     1,080  kcals                         77g protein
                                           26g fiber
     46g protein
                                           912cc free water
     16g fiber                            100% RDI’s vitamins and
                                            minerals
     547cc free water
                                       IV Fluid KVO
   IV Fluid 100cc/hr                  Water Flushes 200cc QID
         *RD recommendation based on Adjusted Body Weight of
         114#
Tests and Procedures
   Chest X-Ray

   Kidney, Ureters, Bladder X-ray (KUB)

   Abdominal Ultrasound

   Conversion G-Tube to G-J Tube

   Abdominal CT Scan with Contrast
Diet Orders
   Tube Feeding via G-Tube
     Jevity1.5 at 30cc/hr
     Held due to projectile vomit



   Gatorade via G-Tube
     30cc/hr

     Held   for testing


   Tube Feeding via G-J Tube
     Jevity   1.5 at 40cc/hr
Discharge Notes
   April 26, 2010

   Approximate 15# Weight Gain
       Positive Fluid Balance

   Discharge to home
       Continue with Home Health Care

   Medical follow ups in two-three weeks

   Resume Jevity bolus of 5 cans daily
Questions?
Works Cited
   1. Astrocytoma. Astrocytoma. 2007. Available at: http://www.astrocytoma.org/. Accessed June 1, 2010.

   2. Glioma. Mayo Clinic. April 2010. Available at: http://www.mayoclinic.org/glioma/. Accessed June 1,
    2010.

   3. Kennedy B, Bruce JN. Astrocytoma. eMedicine Oncology. January 23, 2009. Available at:
    http://emedicine.medscape.com/article/283453-overview. Accessed June 2, 2010.

   4. Brain tumor-primary-adults. Medline Plus Medical Encyclopedia. May 7, 2010. Available at:
    http://www.nlm.nih.gov/medlineplus/ency/article/007222.htm. Accessed June 5, 2010

   5. Adult brain tumor treatment. National Cancer Institute. October 13, 2009. Available at:
    http://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional/page7. Accessed
    June 4, 2010.

   6. Pronsky ZM. Food Medication Interactions. 15th Ed. Birchrunville, PA: Food-Medication Interactions;
    2008.

   7. American Dietetic Association. International Dietetics & Nutrition Terminology Reference Manual. 2nd
    Ed. Chicago, IL: American Dietetic Association; 2009.

A Case Study: Astrocytoma

  • 1.
    ASTROCYTOMA June 9, 2010 Victoria Parry, Dietetic Intern
  • 2.
    Astrocytoma Astrocytoma s normally develop in the cerebrum butcan originate in other parts of the brain and spinal cord.
  • 3.
    Astrocytes Star-shaped glial cellslocated in the brain and spinal cord (CNS) Function: Regulate external chemical environment of neurons; blood flow in brain
  • 4.
    Stages of Astrocytoma  Stage 1: Pilocytic Astrocytoma  Stage 2: Diffuse Astrocytoma  Stage 3: Anaplastic Astrocytoma  Stage 4: Glioblastoma Multiforme (GBM)  Gliosarcoma  Giant Cell Glioblastoma (1)
  • 5.
    Examples of Astrocytomas Low-gradeAstrocytoma Giant Cell Astrocytoma (2)
  • 6.
    Cause of Astrocytoma  Currently unknown  Cell phones  Prophylactic Radiation for Acute Lymphatic Leukemia  Genetics  Family history of astrocytoma  Molecular Mutation (3)
  • 7.
    Prevalence Gender Age  Male predominance  Affects all ages  10% less than 20 years  1.18:1 Low-grade  60% 20-45 years  1.87:1 Anaplastic (Grade  30% 45 years or older III) Race Mortality and Morbidity  Affects all races  Grade 1: 10 years  Grade 2: More than 5 years  Grade 3: 2-5 years  Grade 4: Less than 1 year (3)
  • 8.
    Symptoms  Altered development or growth (in children)  Double Vision  Drowsiness  Eyesight Problems  Headache  Lethargy  Mental Status Change  Obtuseness  Personality Changes  Seizures  Vomiting (1,4
  • 9.
    Diagnosis and Treatment Testing: Treatment Options:  Neurological Exam  Surgery  Vision  Resection of tumor  Hearing  Balance  Radiation  Coordination  Chemotherapy  Computed Tomography  Temozolomide Scan (CT)  Magnetic Resonance Imaging (MRI)  Angiogram  Biopsy (1, 2, 3, 5)
  • 10.
    Case Study PatientInformation • Admit Diagnosis: Aspiration Pneumonia, Dehydration, Sepsis • Sex: Female • Age: 36 Years Old • Weight: 157# • Height: 5’0” • BMI: 31 • Ideal Body Weight: 90-110# • Percent Ideal Body Weight: 157% • Adjusted Body Weight: 114# • Home Diet Regimen: G-Tube with Jevity Bolus 5 Cans Daily
  • 11.
    Past Medical History  Astrocytoma  1987: Cerebral Astrocytoma Surgery  1992: Repeat Brain Surgery  Pituitary Insufficiency  Post radiation treatment  Seizure Disorder  Post brain surgery  Hypothyroidism  Pneumonia  Gastrostomy Tube Placement  2006
  • 12.
    Social History  Resides with mother and other family  Bed bound last 3-4 years  Home Health Care Aide  Three times daily  Nonverbal
  • 13.
    Relevant Medications  Os-Cal: Calcium supplement. Also used as antacid, phosphate binder, antidiarrheal  Prilosec: Proton Pump Inhibitor. Used to decrease gastric acid secretion and increase gastric pH  Lactinex: Lactobacillus probiotic. Used to aid with GI regulation and antidiarrheal  Zofran: Antiemetic. Used to decrease vomiting  Flagyl: Antibiotic used to treat C. diff. (6) Can cause nausea, diarrhea, anorexia,
  • 14.
    Laboratory Values Date Hgb Hct MCV Na+ K+ Gluc. BUN Creat. Ca+ 12-18 37-47 82-101 135-155 3.5-5.5 70-120 8-26 .6-1.3 8.7-10.2 4/18 16.4 49.2 81.8 141 4.4 86 12 0.9 9.1 4/19 14.2 42.1 80.7 135 3.4 97 10 0.9 8.5 4/20 12.3 35.9 80.9 140 3.8 84 5 0.6 8.2 4/21 N/A N/A N/A 145 2.9 73 1 0.6 8.0 4/22 11.4 33.0 79.5 N/A N/A N/A N/A N/A N/A 4/23 N/A N/A N/A 145 2.9 90 2 0.6 8.0 4/24 12.6 37.0 79.8 141 3.4 102 6 0.6 7.7 4/25 12.3 37.0 81.6 143 3.4 86 8 0.5 7.9 4/26 12.6 37.9 82.3 N/A N/A N/A N/A N/A N/A
  • 15.
    Laboratory Values Date Alb Alk Phos SGOT PO4 RBC WBC Cl- 3.4-5.0 50-136 7-47 2.5-4.9 4.2-5.4 4-10.5 96-107 4/18 N/A N/A N/A N/A 6.01 16.2 100 4/19 2.4 339 43 3.2 5.21 18.4 102 4/20 N/A N/A N/A N/A 4.44 12.4 107 4/21 N/A N/A N/A N/A N/A N/A 108 4/22 2.2 232 63 N/A 4.16 7.7 N/A 4/23 2.5 257 58 N/A N/A N/A 107 4/24 2.3 189 32 N/A 4.63 16.7 106 4/25 2.2 187 18 N/A 4.53 14.7 109 4/26 N/A N/A N/A N/A 4.60 13.4 N/A
  • 16.
    Dietary Trigger  Dietary Consult for Tube Feeding Recommendation  Moderately Depleted Albumin Level of 2.4 and Pre-albumin Level of 11.6
  • 17.
    PES Statements  (NC-1.1) Swallowing difficulty related to dysphagia and past medical history as evidenced by patient needing Gastrostomy Tube for main nutrition and hydration support.  (NI-5.1) Increased protein needs related to increased demand for protein as evidenced by moderately depleted albumin level of 2.4 and pre-albumin level of 11.6. (7)
  • 18.
    Interventions  Await restart of tube feedings  Recommend necessary adjustments to tube feeding rate and fluids  Monitor tolerance of tube feeding
  • 19.
    Energy, Protein, andFluid Needs*  Estimated Energy Needs:  1266 (BEE) x 1.2 x 1.1= 1,671 kcals  Estimated Protein Needs:  1.2-1.3g/kg= 62-68g  Estimated Fluid Needs:  35mL/kg= 1,820mL *All needs based on Adjusted Body Weight of 114#
  • 20.
    Tube Feeding Recommendations Initial MDOrder RD Recommended Order*  Jevity 1.5 at 30cc/hr  Jevity 1.5 at 50cc/hr  Provides:  Provides:  1,800 kcals  1,080 kcals  77g protein  26g fiber  46g protein  912cc free water  16g fiber  100% RDI’s vitamins and minerals  547cc free water  IV Fluid KVO  IV Fluid 100cc/hr  Water Flushes 200cc QID *RD recommendation based on Adjusted Body Weight of 114#
  • 21.
    Tests and Procedures  Chest X-Ray  Kidney, Ureters, Bladder X-ray (KUB)  Abdominal Ultrasound  Conversion G-Tube to G-J Tube  Abdominal CT Scan with Contrast
  • 22.
    Diet Orders  Tube Feeding via G-Tube  Jevity1.5 at 30cc/hr  Held due to projectile vomit  Gatorade via G-Tube  30cc/hr  Held for testing  Tube Feeding via G-J Tube  Jevity 1.5 at 40cc/hr
  • 23.
    Discharge Notes  April 26, 2010  Approximate 15# Weight Gain  Positive Fluid Balance  Discharge to home  Continue with Home Health Care  Medical follow ups in two-three weeks  Resume Jevity bolus of 5 cans daily
  • 24.
  • 25.
    Works Cited  1. Astrocytoma. Astrocytoma. 2007. Available at: http://www.astrocytoma.org/. Accessed June 1, 2010.  2. Glioma. Mayo Clinic. April 2010. Available at: http://www.mayoclinic.org/glioma/. Accessed June 1, 2010.  3. Kennedy B, Bruce JN. Astrocytoma. eMedicine Oncology. January 23, 2009. Available at: http://emedicine.medscape.com/article/283453-overview. Accessed June 2, 2010.  4. Brain tumor-primary-adults. Medline Plus Medical Encyclopedia. May 7, 2010. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/007222.htm. Accessed June 5, 2010  5. Adult brain tumor treatment. National Cancer Institute. October 13, 2009. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional/page7. Accessed June 4, 2010.  6. Pronsky ZM. Food Medication Interactions. 15th Ed. Birchrunville, PA: Food-Medication Interactions; 2008.  7. American Dietetic Association. International Dietetics & Nutrition Terminology Reference Manual. 2nd Ed. Chicago, IL: American Dietetic Association; 2009.

Editor's Notes

  • #3 Glioma Tumor
  • #4 http://missinglink.ucsf.edu/lm/ids_104_cns_injury/Response%20_to_Injury/Astrocytes.htmAstrocytes (Astroglia)Most abundant glial cellOther Glial Cells: Oligodendrocytes, Schwann CellsThe most abundant type of macroglial cell, astrocytes (also called astroglia) have numerous projections that anchor neurons to their blood supply. They regulate the external chemical environment of neurons by removing excess ions, notably potassium, and recycling neurotransmitters released during synaptic transmission. The current theory suggests that astrocytes may be the predominant "building blocks" of the blood-brain barrier. Astrocytes may regulate vasoconstriction and vasodilation by producing substances such as arachidonic acid, whose metabolites are vasoactive.
  • #5 Astrocytoma.org
  • #6 Brainstemglioma (low-grade) normally in childrenMayoclinic.org
  • #8 5.4 cases per 100,000 populationNo difference US vs internationalhttp://emedicine.medscape.com/article/283453-overview
  • #9 http://www.astrocytoma.org/http://www.nlm.nih.gov/medlineplus/ency/article/007222.htm
  • #10 Chemotherapy: anaplasticastrocytomahttp://www.mayoclinic.org/glioma/treatment.htmlhttp://emedicine.medscape.com/article/283453-treatmenthttp://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional/page7
  • #12 Previous admissions: 2006: Aspiration Pneumonia, Fever, Weakness 2007: AMS 2009: Pneumonia
  • #15 Received K Bolus
  • #21 Increase from 45cc/hr to increase protein intake1620kcal, 69g protein, 24g fiber, 820 mL fluid
  • #22 http://www.mountnittany.org/assets/images/krames/115616.jpg
  • #23 Tolerated feedings well. Very little residuals of 10-40cc